Background:
Making PDPT acceptable to both patients and partners is crucial to its success as a treatment strategy.

Objective:
To determine the acceptability of PDPT for female CT patients and their male partners

Method:
Between November 2003 and November 2005, women positive for CT in three different clinic settings were offered a choice between PDPT and standard partner notification and completed an initial survey. Male partners receiving PDPT were asked to mail in a survey. Women then completed another survey at a 3-month follow-up visit.


Result:
A total of 130 enrolled women named a total of 152 partners. PDPT was chosen for at least one partner by 88% of the women and 84% of all named partners received PDPT. PDPT was significantly more likely to be chosen for steady as opposed to casual or once-only relationships (OR 5.69, p < 0.05). There were no significant demographic differences between patients that did and did not choose PDPT.
Of the 128 partners receiving PDPT, 25 (20%) completed the survey with 83% stating they took the medication, 59% stating they were comfortable receiving PDPT, 54% saying they were likely to visit a clinic, and 67% saying PDPT was a good idea. No adverse events to PDPT were reported.
Of the 54 women completing follow-up to date, 70% were definite their partner took the medication, 81% were comfortable giving PDPT, 54% thought it was likely their partner visited a clinic, and 95% thought PDPT was a good idea.


Conclusion:
Female patients widely chose PDPT over standard notification irregardless of demographics, clinic setting, or risk factors. PDPT may work best for steady but can also be used for casual relationships.

Implications:
PDPT is widely favored as a CT treatment strategy for female patients and also appears acceptable to male partners.